UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Randomized Phase II Study of Bortezomib Alone and Bortezomib in Combination With Docetaxel in Previously Treated Advanced Non–Small-Cell Lung Cancer

Journal of clinical oncology, 2006-11, Vol.24 (31), p.5025-5033

2006

Volltextzugriff (PDF)

Phase I/II open-label study of the biologic effects of the interleukin-2 immunocytokine EMD 273063 (hu14.18-IL2) in patients with metastatic malignant melanoma

Journal of translational medicine, 2009-07, Vol.7 (1), p.68-68, Article 68

2009

Volltextzugriff (PDF)

Clinical and Immune Responses in Resected Colon Cancer Patients Treated With Anti-Idiotype Monoclonal Antibody Vaccine That Mimics the Carcinoembryonic Antigen

Journal of clinical oncology, 1999-09, Vol.17 (9), p.2889-2895

1999

Volltextzugriff (PDF)

Clinical and Immune Responses in Advanced Melanoma Patients Immunized With an Anti-Idiotype Antibody Mimicking Disialoganglioside GD2

Journal of clinical oncology, 2000-01, Vol.18 (2), p.376-384

2000

Volltextzugriff (PDF)

Immediate-type hypersensitivity and other clinical reactions in volunteers immunized with a synthetic multi-antigen peptide vaccine (PfCS-MAP1NYU) against Plasmodium falciparum sporozoites

Vaccine, 2002-12, Vol.21 (3), p.269-280

2002

Volltextzugriff (PDF)

Trispecific Antibodies for Selective CD16A-Directed NK-Cell Engagement in Multiple Myeloma

Blood, 2016-12, Vol.128 (22), p.4513-4513

2016

Volltextzugriff (PDF)

Highly cytotoxic EGFR/CD16A TandAbs to recruit NK-cells to kill EGFR-expressing tumor cells

Journal of clinical oncology, 2016-05, Vol.34 (15_suppl), p.e14007-e14007

2016

Volltextzugriff (PDF)

A Phase I study of bortezomib plus irinotecan in patients with advanced solid tumors

Cancer, 2006-12, Vol.107 (11), p.2688-2697

2006

Volltextzugriff (PDF)

Phase I clinical trial of bortezomib in combination with gemcitabine in patients with advanced solid tumors

Cancer, 2006-11, Vol.107 (10), p.2482-2489

2006

Volltextzugriff (PDF)

Safety, tolerability and immunogenicity of new formulations of the Plasmodium falciparum malaria peptide vaccine SPf66 combined with the immunological adjuvant QS-21

Vaccine, 2002-05, Vol.20 (17), p.2263-2277

2002

Volltextzugriff (PDF)

Antibody responses in melanoma patients immunized with an anti-idiotype antibody mimicking disialoganglioside GD2

Clinical cancer research, 1998-05, Vol.4 (5), p.1117-1124

1998

Volltextzugriff (PDF)

Bortezomib Plus Docetaxel in Advanced Non-small Cell Lung Cancer and Other Solid Tumors: A Phase I California Cancer Consortium Trial

Journal of thoracic oncology, 2006-02, Vol.1 (2), p.126-134

2006

Volltextzugriff (PDF)

Pharmacogenomics

Advances in anatomic pathology, 2004-07, Vol.11 (4), p.211-220

2004

Volltextzugriff (PDF)

Amino acid dimorphism and parasite immune evasion: cellular immune responses to a promiscuous epitope of Plasmodium falciparum merozoite surface protein 1 displaying dimorphic amino acid polymorphism are highly constrained

European journal of immunology, 2002-12, Vol.32 (12), p.3667-3677

2002

Volltextzugriff (PDF)

Sialic acid-dependent binding of baculovirus-expressed recombinant antigens from Plasmodium falciparum EBA-175 to Glycophorin A

Molecular and biochemical parasitology, 2001-03, Vol.113 (1), p.9-21

2001

Volltextzugriff (PDF)

Bortezomib Plus Docetaxel in Advanced Non-small Cell Lung Cancer and Other Solid Tumors: A Phase I California Cancer Consortium Trial

Journal of thoracic oncology, 2006-02, Vol.1 (2), p.126-134

2006

Volltextzugriff (PDF)

Amino acid dimorphism and parasite immune evasion: cellular immune responses to a promiscuous epitope ofPlasmodium falciparum merozoite surface protein?1 displaying dimorphic amino acid polymorphism are highly constrained

European journal of immunology, 2002-12, Vol.32 (12), p.3667-3677

2002

Volltextzugriff (PDF)

Erratum to “Immediate-type hypersensitivity and other clinical reactions in volunteers immunized with a synthetic multi-antigen peptide vaccine (PfCS-MAP1NYU) against Plasmodium falciparum” [Vaccine 21 (2003) 269–280]

Vaccine, 2003-06, Vol.21 (19), p.2689-2689

2003

Volltextzugriff (PDF)

Infection with human immunodeficiency virus type 1 (HIV-1) and human T cell lymphotropic viruses among leprosy patients and contacts: correlation between HIV-1 cross-reactivity and antibodies to lipoarabinomannan

The Journal of infectious diseases, 1994-02, Vol.169 (2), p.296

1994

Volltextzugriff (PDF)

Generation of chimeric monoclonal antibodies from mice that carry human immunoglobulin C γ1 heavy or C κ light chain gene segments

Journal of immunological methods, 1998-06, Vol.215 (1), p.27-37

1998

Volltextzugriff (PDF)

Hepatitis B virus activation among central Africans infected with human immunodeficiency virus (HIV) type 1: pre-s2 antigen is predominantly expressed in HIV infection

The Journal of infectious diseases, 1994-03, Vol.169 (3), p.628-632

1994

Volltextzugriff (PDF)

Baculovirus-mediated expression of Plasmodium falciparum erythrocyte binding antigen 175 polypeptides and their recognition by human antibodies

Infection and Immunity, 1997-09, Vol.65 (9), p.3631-3637

1997

Volltextzugriff (PDF)

Infection with Human Immunodeficiency Virus Type I (HIV-1) and Human T Cell Lymphotropic Viruses among Leprosy Patients and Contacts: Correlation between HIV-1 Cross-Reactivity and Antibodies to Lipoarabinomannan

The Journal of infectious diseases, 1994-02, Vol.169 (2), p.296-304

1994

Volltextzugriff (PDF)

Isotypic Distribution of HIV-1-Specific Antibodies in Individuals from Central Africa

Viral immunology, 1992, Vol.5 (4), p.243-248

1992

Volltextzugriff (PDF)

Humoral aspects of anti-HIV immune responses in Zairians with AIDS : lower antigenemia does not correlate with immune complex levels

AIDS research and human retroviruses, 1993-03, Vol.9 (3), p.251-258

1993

Volltextzugriff (PDF)

1 – 25 von 26

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(25)
Mit Volltextzugriff
(22)

Publikationsform

Artikel
(25)
Dissertationen
(1)

Sprache

Englisch
(26)

Erscheinungsjahr

n.n

Thema

Humans
(18)
Life Sciences & Biomedicine
(17)
Science & Technology
(17)
Biological And Medical Sciences
(14)
Adult
(11)
Male
(11)
Female
(10)
Medical Sciences
(9)
Middle Aged
(8)
Aged
(7)
Animals
(7)
Immunology
(7)
Oncology
(7)
Bortezomib
(5)
Fundamental And Applied Biological Sciences. Psychology
(5)
Plasmodium Falciparum - Immunology
(5)
Aids/hiv
(4)
Boronic Acids - Administration & Dosage
(4)
Infectious Diseases
(4)
Malaria
(4)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Randomized Phase II Study of Bortezomib Alone and Bortezomib in Combination With Docetaxel in Previously Treated Advanced Non–Small-Cell Lung Cancer

Phase I/II open-label study of the biologic effects of the interleukin-2 immunocytokine EMD 273063 (hu14.18-IL2) in patients with metastatic malignant melanoma

Clinical and Immune Responses in Resected Colon Cancer Patients Treated With Anti-Idiotype Monoclonal Antibody Vaccine That Mimics the Carcinoembryonic Antigen

Clinical and Immune Responses in Advanced Melanoma Patients Immunized With an Anti-Idiotype Antibody Mimicking Disialoganglioside GD2

Immediate-type hypersensitivity and other clinical reactions in volunteers immunized with a synthetic multi-antigen peptide vaccine (PfCS-MAP1NYU) against Plasmodium falciparum sporozoites

Trispecific Antibodies for Selective CD16A-Directed NK-Cell Engagement in Multiple Myeloma

Highly cytotoxic EGFR/CD16A TandAbs to recruit NK-cells to kill EGFR-expressing tumor cells

A Phase I study of bortezomib plus irinotecan in patients with advanced solid tumors

Phase I clinical trial of bortezomib in combination with gemcitabine in patients with advanced solid tumors

Safety, tolerability and immunogenicity of new formulations of the Plasmodium falciparum malaria peptide vaccine SPf66 combined with the immunological adjuvant QS-21

Antibody responses in melanoma patients immunized with an anti-idiotype antibody mimicking disialoganglioside GD2

Bortezomib Plus Docetaxel in Advanced Non-small Cell Lung Cancer and Other Solid Tumors: A Phase I California Cancer Consortium Trial

Pharmacogenomics

Amino acid dimorphism and parasite immune evasion: cellular immune responses to a promiscuous epitope of Plasmodium falciparum merozoite surface protein 1 displaying dimorphic amino acid polymorphism are highly constrained

Sialic acid-dependent binding of baculovirus-expressed recombinant antigens from Plasmodium falciparum EBA-175 to Glycophorin A

Bortezomib Plus Docetaxel in Advanced Non-small Cell Lung Cancer and Other Solid Tumors: A Phase I California Cancer Consortium Trial

Amino acid dimorphism and parasite immune evasion: cellular immune responses to a promiscuous epitope ofPlasmodium falciparum merozoite surface protein?1 displaying dimorphic amino acid polymorphism are highly constrained

Erratum to “Immediate-type hypersensitivity and other clinical reactions in volunteers immunized with a synthetic multi-antigen peptide vaccine (PfCS-MAP1NYU) against Plasmodium falciparum” [Vaccine 21 (2003) 269–280]

Infection with human immunodeficiency virus type 1 (HIV-1) and human T cell lymphotropic viruses among leprosy patients and contacts: correlation between HIV-1 cross-reactivity and antibodies to lipoarabinomannan

Generation of chimeric monoclonal antibodies from mice that carry human immunoglobulin C γ1 heavy or C κ light chain gene segments

Hepatitis B virus activation among central Africans infected with human immunodeficiency virus (HIV) type 1: pre-s2 antigen is predominantly expressed in HIV infection

Baculovirus-mediated expression of Plasmodium falciparum erythrocyte binding antigen 175 polypeptides and their recognition by human antibodies

Infection with Human Immunodeficiency Virus Type I (HIV-1) and Human T Cell Lymphotropic Viruses among Leprosy Patients and Contacts: Correlation between HIV-1 Cross-Reactivity and Antibodies to Lipoarabinomannan

Isotypic Distribution of HIV-1-Specific Antibodies in Individuals from Central Africa

Humoral aspects of anti-HIV immune responses in Zairians with AIDS : lower antigenemia does not correlate with immune complex levels

Suchergebnisse filtern